Multiple Sclerosis Study with Planned Enrollment of 3750 Human Participants
An observational study was planned to enroll 3750 participants with Multiple Sclerosis. The main goal was to assess changes in the number of new white matter lesions over time. However, no results have been posted, and details about the outcomes remain unclear.
- Tags
- #MSResearch
- Most relevant to
- —
- Source
- Read original source
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- No results yet
- Outcome
- Not reported
Why it matters
This study aims to advance understanding of MS by tracking lesion progression, which is important for demonstrating disease activity and could have implications for future research and treatment strategies.
What this does not prove
The lack of posted results means no conclusions can be drawn about the study's outcomes or its effectiveness in measuring the rate of change in lesions.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Observational
- Participants / samples
- 3750 · planned enrolment
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- Not reported
- Evidence reviewed
- Trial registry record
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- participants with Multiple Sclerosis (MS) ages from 18 to 120 years
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
Supporting passages (10)
study designStudy type: Observational
subjectsParticipants: people; ages from 18 Years to 120 Years; sex All
sample sizeEnrollment: 3750 participants (estimated)
primary endpointPrimary endpoints: the rate of change in the number of new white matter lesions per participant
population"studyPopulation": "-MS/CIS/RIS population-Patients with a diagnosis of MS or who have typical imaging abnormalities associated with MS.-Non-MS comparison populations-Patients with disorders of the CNS, to include patients with diseases that share mechanisms of tissue damage with MS, such as mitochondrial disorders, leukodystrophies, neurodegenerative diseases that may cause axonal loss or oxidative stress, and chronic small vessel disease.-Healthy volunteers-Healthy volunteers for technique development and comparison with the patient populations.",
limitationsNo results are posted. Planned enrolment and endpoints are not findings.
findingsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
peer reviewedTrial registry record.
follow upFollow-up: baseline vs. follow up visits
sample size basisEnrollment: 3750 participants (estimated)
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.